Data for goal disturbance, cortisol levels, CAR, DCS, and COMT over time (n = 72).

<p>Paired samples t-tests were used to test significant differences between time 2 and time 3, and ANOVA’s with COMT genotype as between-group factor to test significant differences in cortisol levels between genotypes.</p

Flowchart of patients who provided useful samples.

<p>Flowchart of patients who provided useful samples.</p

Hierarchical regression analyses predicting cortisol 18 months post-diagnosis (Time 3).

<p>*<i>p</i> < 0.05</p><p>**<i>p</i> < 0.01</p><p>Hierarchical regression analyses predicting cortisol 18 months post-diagnosis (Time 3).</p

Patients’ demographics.

<p>(n = 72) (percentages may not add up to 100% due to missing data).</p><p>Patients’ demographics.</p

Hierarchical regression analyses predicting cortisol 7 months post-diagnosis (Time 2).

<p>*<i>p</i> < 0.05</p><p>**<i>p</i> < 0.01</p><p>Hierarchical regression analyses predicting cortisol 7 months post-diagnosis (Time 2).</p

Patient characteristics and summary of primary outcome scores for the first round and second round evaluations.

<p>Patient characteristics and summary of primary outcome scores for the first round and second round evaluations.</p

Extended questionnaires for the fear of recurrence.

<p>Extended questionnaires for the fear of recurrence.</p

Questionnaires regarding patients' experiences of the intensified follow-up protocol.

<p>Questionnaires regarding patients' experiences of the intensified follow-up protocol.</p

Consort diagram of the CEAwatch trial.

<p>Consort diagram of the CEAwatch trial.</p

Example of a choice set presented in the questionnaire.

<p>Example of a choice set presented in the questionnaire.</p